As­traZeneca, Dai­ichi Sankyo tease new En­her­tu da­ta — but de­tails re­main un­der wraps

As­traZeneca and Dai­ichi Sankyo have new da­ta re­gard­ing their block­buster HER2-tar­get­ed ADC En­her­tu, but they won’t say ex­act­ly what’s com­ing down the pike.

The part­ners …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER